Iran's pharmaceuticalmarket was worth $3.51 billion in 2012, and is expected to grow at an annual average rate of 13% to 2014, after which market growth will steady at 8%, say new forecasts. Expenditure on pharmaceuticals is expected to reach $4.14 billon by 2019 with a compound annual growth rate (CAGR) of 11%, taking inflation into account, says ...

Strong opportunities exist for private investment, especially in medical devices and specialized medicines LONDON,July 24, 2013/PRNewswire/ --Iran'shealthcare industry is set for a bright future. The country is ranked 15thamong Middle EastandAfrica(MEA) countries in terms of long-term investment potential. With a population of 75 million people ...